companydata.dkDraupnir Bio ApS: Financial statements 2024
CVR: 38546880
Draupnir Bio ApS (CVR 38546880) has filed annual accounts for 2024. Equity amounted to DKK 27,633,000. The solvency ratio was 78.9%. The company had 8 employees in the financial year.
- Equity
- 27,633,000 kr.
- Total Assets
- 35,033,000 kr.
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | - | 27.6 mio. | 8 |
| 2023 | - | - | -41.2 mio. | 29.4 mio. | 10 |
| 2022 | - | - | -39.9 mio. | 18.6 mio. | 13 |
| 2021 | - | - | -67 mio. | 53.5 mio. | - |
| 2020 | - | - | -60.6 mio. | 54.2 mio. | - |
How creditworthy is Draupnir Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of July 10, 2024, Novo Holdings A/S is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
As of July 10, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
As of July 10, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.
Draupnir Bio ApS has published its annual report for 2023. The net result was DKK -41,166,000.
As of March 26, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.
About Draupnir Bio ApS
Draupnir Bio ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Thomas Hotchkiss. The company's owners include Novo Holdings A/S, Coöperatieve Gilde Healthcare IV U.A. and Danmarks Eksport- og Investeringsfond. Equity amounted to DKK 15,256,000.